HBP 2016

Hypertrophie* bénigne*de*la*prostate*(HBP)*
!"#$%&' ()*)+,-+.!+/0123'-/4-5+,-+-
4%&+6&7,-/82,',9)-
:;.<=.=<:>
1

Cas*clinique
?$'@,-)+ AB >C &'@ @- D+1@-'E- F2& D%&+6&7,- &G-7 2H$+*$''&'7-
@),G&'E-I
J!"#$%&'%()*"+, -.// 01 (2&34 #,+5)+6 74%8$9
4&@ *H(K8! D&+E,7)2,-+ FD&+E )'- %5D-+E-'@,$' &+E1+,-22- E+&,E1- D&+
L,E%1+&D,-
J!)+5:9)$6)+3;<5$%*;'%$%6;")="5, >? 013>2@. 01 >34
8$6DE-ME-') *- @$' NO-B 2- 61*-7,' 2), &1O&2-6-'E D+-@7+,E
JP' *$@&O- *) 4Q( I'$+6&2
JR8SP ID&@ *- D+$E1,')+,-B', *H%16&E)+,-
2

Cas*clinique
(*,@E&'7- *- 2H1D,@$*- ,'T-7E,-)UB )' L,2&' 72,',9)- -E )+$2$O,9)- -@E T&,E I
JV'E-++$O&E$,+-
JQ-'E,6-'E *- G,*&'O- ,'7$6D23E-
J!-D),@ 9)-29)-@ E-6D@B D$22&W,)+,- '$7E)+'-
J82,',9)- I
JK$)7%-+ +-7E&2
JQ7$+- V4QQ X,'E-+'&E,$'&2 D+$@E&E,7 @56DE$6 @7$+-Y I >
JS,$2$O,9)-
J"1@)2E&E@ *$@&O- 4Q(
JS,$2$O,-
JS&'*-2-EE- )+,'&,+-
JZ17%$O+&D%,-
3
8-@/1216-'E@/D-+6-EE-'E/*-/*,&O'$@E,9)-+/)'-/
%5D-+E+$D%,-/L1',O'-/*-/2&/D+$@E&E-/21O3+-

Score* international
4

Généralités
!1T,',E,$'
J[E&E *- 2& '&E)+- D2)@ 9)H)'- D&E%$2$O,-\
J('&E$6,9)-6-'E I&)O6-'E&E,$' *- 2& E&,22- *- 2& D+$@E&E- '$' *)- F)'
7&'7-+B
J0,@E$2$O,9)-6-'E I%5D-+D2&@,- *- 2& ]$'- E+&'@,E,$''-22- *- 2& D+$@E&E-\
4+1G&2-'7-
!&G-7/2HNO-/I/^_0S4/-@E/T+19)-'E-/7%-]/2_%$66-/*-/D2)@/*-/C< &'@\/R22-/-@E/
%,@E$2$O,9)-6-'E/D+1@-'E-/7%-]/2&/6$,E,1/*-@/D&E,-'E@/*-/`C &'@B/7%-]/;< a/
*-/7-)U/*-/>< &'@/-E/:<< a/*-/7-)U/*-/b< &'@\
c$' D+1*,7E,T *H)' 7&'7-+ *- 2& D+$@E&E-
5